Amazon Malaria Initiative

News

AMI USAID
Key Interventions Strengthen Health Systems to Address Malaria in Guatemala

May 2, 2016
Description: To achieve the goal of eliminating malaria in Guatemala, timely access to the appropriate treatment is a key strategy for the Ministry of Health and Social Assistance. After an assessment of the management of medicines and diagnostic supplies for malaria, the Systems for Improved Access to Pharmaceuticals and Services Program (SIAPS), in partnership with PAHO/WHO and Links Media, has been providing technical assistance to the ministry’s malaria sub-program for nationwide rollout of a set of interventions to improve management of malaria commodities. Find out more here.

World Malaria Day 2016: End Malaria for Good in the Americas

April 25, 2016
Description: “End malaria for good” is the theme for World Malaria Day on April 25, 2016. In 2015, the Americas celebrated having reduced malaria by 67% since the year 2000, and so far 18 countries in the region have committed to eliminating the disease in the coming years.


This is not the first time that countries of the Americas have set their sights on malaria elimination. Global eradication was proposed in the 1950s and 1960s. At that time, some countries successfully put an end to malaria, while others experienced a resurgence of the disease after coming very close to elimination. From this experience, we have learned that political and financial commitments have to be sustained over time. Moreover, we learned that we could not depend on the use of DDT as a single solution, but rather that the success of any elimination plan depends on the deployment of numerous components such as diagnosis, treatment, integrated vector management, surveillance, and communication.


We have also learned that when cases become increasingly few in number, control efforts and financial resources are often diminished, and health systems lose the capacities needed to successfully manage the disease and prevent outbreaks. Furthermore, the situation worsens and the threat increases for populations in remote areas, such as those that reside in the Amazon region and have limited access to quality health services for diagnosis and treatment. For their part, vectors and parasites adapt more rapidly to prevention and control measures implemented by countries. Parasites that become resistant to medicines — and malaria-transmitting mosquitoes that become resistant to insecticides — present great challenges, and threaten the progress made to date.


In spite of the difficulties, most countries have been able to accelerate efforts against malaria. With technical assistance obtained through regional networks like the Amazon Malaria Initiative (AMI) and the Amazon Network for the Surveillance of Antimalarial Drug Resistance (RAVREDA, by its Spanish acronym), countries of the Americas are well positioned to eliminate malaria. Such networks enable the coordination of operational research, the exchange of data, the supply of life-saving medicines, and the reinforcement of local capacity to confront malaria.


Since the year 2000, countries of the region have invested a great deal of time and money in reducing the number of cases of malaria. Nonetheless, with nearly 121 million people at risk of contracting the disease in the Americas, malaria continues to be a problem, having recently rebounded in countries such as Guyana, Nicaragua, Peru, and Venezuela. Therefore, national authorities should continue with concerted efforts to eliminate malaria.

Forum of Malaria Networks and Advocates and the regional launch of the Action and Investment to Defeat Malaria (AIM)

November 5, 2015
Location: Room B, PAHO Headquarters, Washington, D.C.
Description: From 1:00pm – 4:00pm, The Pan American Health Organization, in coordination with the UN Foundation, The Milken Institute School of Public Health at the George Washington University, and the Center for Communication Programs at The Johns Hopkins Bloomberg School of Public Health, will host the Forum of Malaria Networks and Advocates and the regional launch of the Action and Investment to Defeat Malaria (AIM) in commemoration of Malaria Day in the Americas 2015. The event will feature videos, presentations and discussions on the work of Honduras, Paraguay, and Brazil, the three finalists for the ‘Malaria Champions of the Americas 2015’ award.


To RSVP, please fill out the form here.

Closing Ceremony for the Colombia Malaria Project

April 25, 2015
Description: After five years of work, the Colombia Malaria Project came to an end. At the formal closing ceremony in Bogotá, responsibility for institutionalizing the achievements and lessons learned, as well as sustaining efforts against malaria to overcome challenges, was transferred to the Ministry of Health and Social Protection (MSPS), the National Institute of Health (INS), and the territorial entities, with support from AMI/RAVREDA partners. Read the news release and watch interviews with the former project manager, government officials, and PAHO/WHO advisors here (In Spanish).

World Malaria Day 2015

April 25, 2015
Description: The Amazon Malaria Initiative (AMI) recognizes the need for more research on malaria in pregnancy in Latin America and the Caribbean. The US Centers for Disease Control and Prevention (CDC) estimate that 4 in 100 pregnancies in the region are affected by malaria. The negative effects of malaria in pregnancy include prematurity, low birth weight, miscarriages, stillbirth, and congenital malaria in infants. In addition, malaria in pregnant women can result in anemia, an increased risk of severe malaria, and even death. As most of the region has a low incidence of malaria, intermittent preventive treatment in pregnancy (IPTp) is not recommended in Latin America and the Caribbean.


Detecting and treating malaria in pregnant women is important in order to defeat malaria in Latin America and the Caribbean. AMI partners such as the CDC recommend that pregnant women be screened for malaria at each antenatal care visit. Pregnant women who are diagnosed with malaria should receive differentiated treatment according to the treatment guidelines of each country. As with the general population, prompt and effective diagnosis is encouraged along with the use of insecticide-treated bed nets.


AMI has developed a set of region specific Strategic Orientation Documents with guidelines for malaria. The Strategic Orientation Documents cover the topics of drug resistance monitoring in low-incidence settings, vector control, pharmaceutical management, and medicine quality control. They can be found on the AMI Resources page and on the RAVREDA website. Click Here.

Malaria Partners' Meeting and XIV AMI/RAVREDA Annual Evaluation Meeting

March 23-26, 2015
Location: Rio de Janeiro, Brazil
Description: The Pan American Health Organization, in coordination with the Ministry of Health of Brazil, will host the annual AMI/RAVREDA international partners' meeting in Rio de Janeiro from March 24-26, 2015. The meeting's purpose is to review progress, lessons learned, and the implementation of tools developed by AMI/RAVREDA partners. Malaria-endemic countries' ministries of health that are on the frontlines of regional efforts against malaria will be present. Representatives of the United States Agency for International Development (USAID), US Centers for Disease Control and Prevention (CDC), US Pharmacopeial Convention (USP), the USAID-funded Systems for Improved Access to Pharmaceuticals and Services Program (SIAPS), and Links Media will attend on behalf of AMI/RAVREDA. Prior to the official opening, a Malaria Partners' Meeting is also planned with other entities such as the Mexican Agency for International Development Cooperation (AMEXCID), the Clinton Health Access Initiative (CHAI), Global Fund to Fight AIDS, TB, and Malaria, the Haiti Malaria Elimination Consortium (HaMEC), IS Global, and Population Services International (PSI).

Haiti Malaria Elimination Consortium (HaMEC) Is Formed

February 26, 2015
Description: The Bill and Melinda Gates Foundation has awarded a $29.9 million grant to the US Centers for Disease Control and Prevention to lead the new Haiti Malaria Elimination Consortium (HaMEC). HaMEC's objective will be to eliminate malaria from the island of Hispaniola by 2020. Eight other institutions make up the consortium. "We laud this expression of solidarity with efforts to eliminate malaria from the only two countries in the Caribbean [Haiti and the Dominican Republic] where transmission still exists..." said Dr. Keith Carter, Senior Advisor on Malaria and other Communicable Diseases with the Pan American Health Organization/World Health Organization, a consortium partner.

Latest News.

  • Key Interventions Strengthen Health Systems to Address Malaria in Guatemala
  • World Malaria Day 2016: End Malaria for Good in the Americas
  • Forum of Malaria Networks and Advocates and the regional launch of the Action and Investment to Defeat Malaria (AIM)
  • Closing Ceremony for the Colombia Malaria Project
  • World Malaria Day 2015
  • Malaria Partners' Meeting and XIV AMI/RAVREDA Annual Evaluation Meeting
  • Haiti Malaria Elimination Consortium (HaMEC) Is Formed

May 2, 2016
Description: To achieve the goal of eliminating malaria in Guatemala, timely access to the appropriate treatment is a key strategy for the Ministry of Health and Social Assistance. After an assessment of the management of medicines and diagnostic supplies for malaria, the Systems for Improved Access to Pharmaceuticals and Services Program (SIAPS), in partnership with PAHO/WHO and Links Media, has been providing technical assistance to the ministry’s malaria sub-program for nationwide rollout of a set of interventions to improve management of malaria commodities. Find out more here.

April 25, 2016
Description: “End malaria for good” is the theme for World Malaria Day on April 25, 2016. In 2015, the Americas celebrated having reduced malaria by 67% since the year 2000, and so far 18 countries in the region have committed to eliminating the disease in the coming years.


This is not the first time that countries of the Americas have set their sights on malaria elimination. Global eradication was proposed in the 1950s and 1960s. At that time, some countries successfully put an end to malaria, while others experienced a resurgence of the disease after coming very close to elimination. From this experience, we have learned that political and financial commitments have to be sustained over time. Moreover, we learned that we could not depend on the use of DDT as a single solution, but rather that the success of any elimination plan depends on the deployment of numerous components such as diagnosis, treatment, integrated vector management, surveillance, and communication.


We have also learned that when cases become increasingly few in number, control efforts and financial resources are often diminished, and health systems lose the capacities needed to successfully manage the disease and prevent outbreaks. Furthermore, the situation worsens and the threat increases for populations in remote areas, such as those that reside in the Amazon region and have limited access to quality health services for diagnosis and treatment. For their part, vectors and parasites adapt more rapidly to prevention and control measures implemented by countries. Parasites that become resistant to medicines — and malaria-transmitting mosquitoes that become resistant to insecticides — present great challenges, and threaten the progress made to date.


In spite of the difficulties, most countries have been able to accelerate efforts against malaria. With technical assistance obtained through regional networks like the Amazon Malaria Initiative (AMI) and the Amazon Network for the Surveillance of Antimalarial Drug Resistance (RAVREDA, by its Spanish acronym), countries of the Americas are well positioned to eliminate malaria. Such networks enable the coordination of operational research, the exchange of data, the supply of life-saving medicines, and the reinforcement of local capacity to confront malaria.


Since the year 2000, countries of the region have invested a great deal of time and money in reducing the number of cases of malaria. Nonetheless, with nearly 121 million people at risk of contracting the disease in the Americas, malaria continues to be a problem, having recently rebounded in countries such as Guyana, Nicaragua, Peru, and Venezuela. Therefore, national authorities should continue with concerted efforts to eliminate malaria.

November 5, 2015
Location: Room B, PAHO Headquarters, Washington, D.C.
Description: From 1:00pm – 4:00pm, The Pan American Health Organization, in coordination with the UN Foundation, The Milken Institute School of Public Health at the George Washington University, and the Center for Communication Programs at The Johns Hopkins Bloomberg School of Public Health, will host the Forum of Malaria Networks and Advocates and the regional launch of the Action and Investment to Defeat Malaria (AIM) in commemoration of Malaria Day in the Americas 2015. The event will feature videos, presentations and discussions on the work of Honduras, Paraguay, and Brazil, the three finalists for the ‘Malaria Champions of the Americas 2015’, award.


To RSVP, please fill out the form here.

April 25, 2015
Description: After five years of work, the Colombia Malaria Project came to an end. At the formal closing ceremony in Bogotá, responsibility for institutionalizing the achievements and lessons learned, as well as sustaining efforts against malaria to overcome challenges, was transferred to the Ministry of Health and Social Protection (MSPS), the National Institute of Health (INS), and the territorial entities, with support from AMI/RAVREDA partners. Read the news release and watch interviews with the former project manager, government officials, and PAHO/WHO advisors here (In Spanish).

April 25, 2015
Description: The Amazon Malaria Initiative (AMI) recognizes the need for more research on malaria in pregnancy in Latin America and the Caribbean. The US Centers for Disease Control and Prevention (CDC) estimate that 4 in 100 pregnancies in the region are affected by malaria. The negative effects of malaria in pregnancy include prematurity, low birth weight, miscarriages, stillbirth, and congenital malaria in infants. In addition, malaria in pregnant women can result in anemia, an increased risk of severe malaria, and even death. As most of the region has a low incidence of malaria, intermittent preventive treatment in pregnancy (IPTp) is not recommended in Latin America and the Caribbean.


Detecting and treating malaria in pregnant women is important in order to defeat malaria in Latin America and the Caribbean. AMI partners such as the CDC recommend that pregnant women be screened for malaria at each antenatal care visit. Pregnant women who are diagnosed with malaria should receive differentiated treatment according to the treatment guidelines of each country. As with the general population, prompt and effective diagnosis is encouraged along with the use of insecticide-treated bed nets.


AMI has developed a set of region specific Strategic Orientation Documents with guidelines for malaria. The Strategic Orientation Documents cover the topics of drug resistance monitoring in low-incidence settings, vector control, pharmaceutical management, and medicine quality control. They can be found on the AMI Resources page and on the PAHO website. Click Here.

March 23-26, 2015
Location: Rio de Janeiro, Brazil
Description: The Pan American Health Organization, in coordination with the Ministry of Health of Brazil, will host the annual AMI/RAVREDA international partners' meeting in Rio de Janeiro from March 24-26, 2015. The meeting's purpose is to review progress, lessons learned, and the implementation of tools developed by AMI/RAVREDA partners. Malaria-endemic countries' ministries of health that are on the frontlines of regional efforts against malaria will be present. Representatives of the United States Agency for International Development (USAID), US Centers for Disease Control and Prevention (CDC), US Pharmacopeial Convention (USP), the USAID-funded Systems for Improved Access to Pharmaceuticals and Services Program (SIAPS), and Links Media will attend on behalf of AMI/RAVREDA. Prior to the official opening, a Malaria Partners' Meeting is also planned with other entities such as the Mexican Agency for International Development Cooperation (AMEXCID), the Clinton Health Access Initiative (CHAI), Global Fund to Fight AIDS, TB, and Malaria, the Haiti Malaria Elimination Consortium (HaMEC), IS Global, and Population Services International (PSI).

February 26, 2015
Description: The Bill and Melinda Gates Foundation has awarded a $29.9 million grant to the US Centers for Disease Control and Prevention to lead the new Haiti Malaria Elimination Consortium (HaMEC). HaMEC's objective will be to eliminate malaria from the island of Hispaniola by 2020. Eight other institutions make up the consortium. "We laud this expression of solidarity with efforts to eliminate malaria from the only two countries in the Caribbean [Haiti and the Dominican Republic] where transmission still exists..." said Dr. Keith Carter, Senior Advisor on Malaria and other Communicable Diseases with the Pan American Health Organization/World Health Organization, a consortium partner.

Malaria-Related News
AMI's Events Calendar

News archive

Last updated on: 5/2/2016